Compare FND & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FND | GRFS |
|---|---|---|
| Founded | 2000 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.4B |
| IPO Year | 2014 | N/A |
| Metric | FND | GRFS |
|---|---|---|
| Price | $56.77 | $7.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 2 |
| Target Price | ★ $73.44 | $10.15 |
| AVG Volume (30 Days) | ★ 2.5M | 573.0K |
| Earning Date | 04-30-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | ★ 1.05 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $4,684,088,000.00 | N/A |
| Revenue This Year | $7.53 | $4.49 |
| Revenue Next Year | $7.68 | $6.42 |
| P/E Ratio | $139.08 | ★ $18.67 |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $42.64 | $7.16 |
| 52 Week High | $92.41 | $11.14 |
| Indicator | FND | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 63.14 | 36.24 |
| Support Level | $46.29 | N/A |
| Resistance Level | $64.23 | $7.73 |
| Average True Range (ATR) | 2.98 | 0.17 |
| MACD | 0.47 | -0.02 |
| Stochastic Oscillator | 99.37 | 22.31 |
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.